World’s first diagnostic test that can detect all bacterial species in a single...
World’s first diagnostic test that can detect all bacterial species in a single assay
Every year, bacterial infections cause 20% of human deaths. These deaths can be avoided only if the patients are administered correct medical treatment without any delays. Today, the diagnostic tests used to detect and identify ba...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ResisTEST
Developing a rapid diagnostic kit for antibiotic resistance
150K€
Cerrado
MAGTEST
MAGTEST Simple and specific next generation lab on a chip i...
71K€
Cerrado
RAPID
Rapid Antimicrobial susceptibility testing and phylogenetic...
150K€
Cerrado
Biotrack-MED
Diagnostics device for rapid identification and antibiotics...
71K€
Cerrado
AntibioDx
AntibioDx A groundbreaking in vitro diagnostic device with...
71K€
Cerrado
BacterOMIC
Intelligence for precision therapies against antimicrobial r...
3M€
Cerrado
Información proyecto Molecular Culture
Duración del proyecto: 24 meses
Fecha Inicio: 2023-08-15
Fecha Fin: 2025-08-31
Líder del proyecto
INBIOME BV
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
5M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Every year, bacterial infections cause 20% of human deaths. These deaths can be avoided only if the patients are administered correct medical treatment without any delays. Today, the diagnostic tests used to detect and identify bacteria are too slow or not comprehensive enough. Often, doctors have no other option, but to administer treatment through antibiotics based on educated guesswork which can lead to medical complications, in addition to increased patient care costs. To address these issues, Inbiome is developing a cost-effective diagnostic test called Molecular Culture which detects and identifies all bacterial species with 100% accuracy and delivers results within 4 hours. During the EIC project, Inbiome will perform an implementation trial of Molecular Culture in a live hospital setting, optimizing the interface for hospital workflows, clinical validation of additional sample types, adding Anti-Microbial Resistance testing in the workflow, and expanding commercial skills.